Current evidence does not support routine clinical use of GLP-1 medications specifically for alcohol cravings, and patients with alcohol use disorder should be referred to evidence-based treatments including behavioral interventions, mutual support groups, and FDA-approved pharmacotherapies such as naltrexone, acamprosate, and disulfiram
NAD+ and tirzepatide is another combination some users explore for energy and metabolic support
For example, if a patient maintains stable weight reduction for a year but then loses more weight after 6 months on the same GLP-1RA dose, secondary causes should be investigated, especially due to a higher malignancy risk in patients with obesity
These results surpassed even the impressive phase 2 data, and they used a refined titration schedule that incorporated lessons from the earlier trial
Leah Joseph How Does Ozempic Work Compared to Natural GLP1